Abstract
Background: Conventional approaches to management of congestive heart failure (CHF) rely on drugs that increase myocardial contractility or reduce ventricular afterload. These approaches often improve cardiac symptoms and survival, but may be associated with significant deleterious effects. An alternative approach is to enhance myocardial energy production. Dichloroacetate (DCA) stimulates pyruvate dehydrogenase activity and accelerates aerobic glucose, pyruvate, and lactate metabolism in myocardial cells. These alterations would be expected to improve myocardial function.
Hypothesis: The purpose of the investigation was to assess the efficacy of DCA in patients with left ventricular systolic dysfunction and to examine the mechanism by which improvement occurs.
Methods: A total of 25 patients (16 men, 9 women; age range 31‐72 years, mean 59) with CHF and ejection fraction ≤40% received an intravenous infusion of 50 mg/kg DCA over 15 min. Indices of systolic and diastolic function were obtained by two‐dimensional and Doppler echocardiography performed at baseline, 30 min, and 60 min following completion of DCA infusion.
Results: Baseline ventricular ejection fraction was 27.3 ± 9.1%; 17 patients (68%) had nonischemic cardiomyopathy. Heart rate increased after DCA infusion from 73.9 ± 14.5 to 79.2 ± 14.9 beats/min at 60 min; p = 0.02. Left ventricular diastolic and systolic volumes increased at 30 min compared with baseline (248.7 ± 98.1 vs. 259.6 ± 99.6; p = 0.04, and 180.1 ± 80.4 vs. 192.2 ± 84.9; p = 0.002, respectively), but stroke volume (49.2 ± 19.1 vs. 48.9 ± 18.1; p = 0.9) and ejection fraction (27.3 ± 9.1 vs. 25.7 ± 9.8; p = 0.2) were un changed. Indices of diastolic function were also unchanged.
Conclusion: Dichloroacetate infusion in patients with CHF is not associated with improvement in noninvasively assesse left ventricular function.
Keywords: heart failure, dichloroacetate, echocardiography
Full Text
The Full Text of this article is available as a PDF (468.2 KB).
REFERENCES
- 1. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis JM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL: Effect of oral milrinone on mortality in severe congestive heart failure. The PROMISE Study Research Group. NEngl J Med 1991; 325: 1468–1475 [DOI] [PubMed] [Google Scholar]
- 2. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK: Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of PROVED trial. PROVED Investigative Group. J Am Coll Cardiol 1993; 22: 955–962 [DOI] [PubMed] [Google Scholar]
- 3. Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ: Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm. J Am Coll Cardiol 1997; 29: 1206–1213 [DOI] [PubMed] [Google Scholar]
- 4. The Digitalis Investigation Group : The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525–533 [DOI] [PubMed] [Google Scholar]
- 5. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders, Fletcher RD , Loeb HS, Hughes VC, Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314: 1547–1552 [DOI] [PubMed] [Google Scholar]
- 6. The CONSENSUS Trial Study Group : Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);. N Engl J Med 1987; 316: 1429–1435 [DOI] [PubMed] [Google Scholar]
- 7. The SOLVD Investigators : Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–302 [DOI] [PubMed] [Google Scholar]
- 8. Strauer BE: Myocardial oxygen consumption in chronic heart disease: Role of wall stress, hypertrophy and coronary reserve. Am J Cardiol 1979; 44: 730–740 [DOI] [PubMed] [Google Scholar]
- 9. Weber KT, Janicki JS: The metabolic demand and oxygen supply of the heart: Physiologic and clinical considerations. Am J Cardiol 1989; 44: 722–729 [DOI] [PubMed] [Google Scholar]
- 10. Takaoka H, Takeuchi M, Odake M, Hayashi Y, Hata K, Mori M, Yokoyama M: Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricle. Circulation 1993; 87: 59–69 [DOI] [PubMed] [Google Scholar]
- 11. Stacpoole PW: The pharmacology of dichloroacetate. Metabolism 1989; 38: 1124–1144 [DOI] [PubMed] [Google Scholar]
- 12. Bersin RM, Stacpoole PW: Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J 1997; 134: 841–855 [DOI] [PubMed] [Google Scholar]
- 13. Wargovich TJ, Macdonald RG, Hill JA, Feldman RL, Stacpoole PW, Pepine CJ: Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol 1988; 61: 65–70 [DOI] [PubMed] [Google Scholar]
- 14. Bersin RM, Wolfe C, Kwasman M, Lau D, Kliniski C, Tanaka K, Khorrami P, Henderson GN, deMarco T, Chatterjee K: Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol 1994; 23: 1617–1624 [DOI] [PubMed] [Google Scholar]
- 15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I: American Society of Echocardiography Committee of Standards. Recommendation for quantitation of the left ventricle by two‐dimensional echocardiography. J Am Soc Echo 1989; 2: 358–367 [DOI] [PubMed] [Google Scholar]
- 16. Rokey R, Kuo LC, Zogbi WA, Limacher MC, Quinones MA: Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: Comparison with cineangiography. Circulation 1985; 71: 543–550 [DOI] [PubMed] [Google Scholar]
- 17. Nishimura RA: Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. Part II. Clinical studies. Mayo Clin Proc 1989; 64: 181–204 [DOI] [PubMed] [Google Scholar]
- 18. Keren G, Sherez J, Megidesh R, Levitt B, Laniado S: Pulmonary venous flow pattern‐its relationship to cardiac dynamics. Circulation 1985; 71: 1105–1122 [DOI] [PubMed] [Google Scholar]
- 19. Nishimura RA, Abel MD, Hatle LK, Tajik AJ: Relation of pulmonary vein to mitral flow velocities by transesophageal Doppler echocardiography. Circulation 1990; 81: 488–497 [DOI] [PubMed] [Google Scholar]
- 20. Lewis JF, Kuo LC, Nelson JG, Limacher MC, Quinones MA: Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: Clinical validation of two new methods using the apical window. Circulation 1984; 70: 425–431 [DOI] [PubMed] [Google Scholar]
- 21. Himelman RB, Cassidy MM, Landzberg JS, Schiller NB: Reproducibility of quantitative two‐dimensional echocardiography. Am Heart J 1988; 115: 425–431 [DOI] [PubMed] [Google Scholar]
- 22. DeMarco T, Chatterjee K, Rouleau JL, Parmley WW: Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J 1988; 115: 809–815 [DOI] [PubMed] [Google Scholar]
- 23. Hasenfuss G, Holubarsch C, Heiss HW, Meinertz T, Bonzel T, Wais U, Lehmann M, Just H: Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone. Circulation 1989; 80: 51–64 [DOI] [PubMed] [Google Scholar]
- 24. Suga H, Hisano R, Goto Y, Yamada O, Igarashi Y: Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ Res 1983; 53: 306–318 [DOI] [PubMed] [Google Scholar]
- 25. Liedtke JA, Nellis S, Neely JR: Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Circ Res 1978; 43: 652–661 [DOI] [PubMed] [Google Scholar]
- 26. Vik‐Mo H, Mjos OD: Influence of free fatty acid on myocardial oxygen consumption and ischemic injury. Am J Cardiol 1981; 48: 361–365 [DOI] [PubMed] [Google Scholar]
- 27. Kahles H, Hellige G, Hunneman DH, Mezger VA, Bretschneider HJ: Influence of myocardial substrate utilization on oxygen consumption of the heart. Clin Cardiol 1982; 5: 286–293 [DOI] [PubMed] [Google Scholar]
- 28. McAllister A, Allison, SP , Randle PJ: Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3‐hydroxybutyrate and pulmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo. Biochem J 1973; 134: 1067–1081 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Whitehouse S, Randle PJ: Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate. Biochem J 1973; 134: 651–653 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Bums AH, Summer, WR , Burns LA, Shepherd RE: Inotropic interactions of dichloroacetate with amrinone and ouabain in isolated hearts from endotoxin‐shocked rats. J Cardiovasc Pharmacol 1988; 11: 379–386 [DOI] [PubMed] [Google Scholar]
- 31. Mjos OD, Miller NE, Riemersma RA, Oliver MF: Effects of dichloroacetate on myocardial substrate extraction, epicardial ST‐segment elevation and ventricular blood flow following coronary occlusion in dogs. Cardiovasc Res 1976; 10: 427–436 [DOI] [PubMed] [Google Scholar]
- 32. Burns AH, Giaimo ME, Summer WR: Dichloroacctic acid improves in vitro myocardial function following in vivo endotoxin administration. J Crit Care 1986; 1: 11–17 [Google Scholar]
- 33. Burns AH, Summer WR, Racey‐Burns LA. Shepherd RE: Inotropic interactions of dichloroacetate with amrinone and ouabain in isolated hearts from endotoxin‐shocked rats. J Cardiovasc Pharmacol 198; 1: 379–386 [DOI] [PubMed] [Google Scholar]